Publikationen 2013

  1. Noninvasive analysis of synthetic and decellularized scaffolds for heart valve tissue engineering.
    Haller N, Hollweck T, Thierfelder N, Schulte J, Hausherr JM, Dauner M, Akra B
    ASAIO J. 2013;59(2): 169-77

  2. In vitro comparison of novel polyurethane aortic valves and homografts after seeding and conditioning.
    Thierfelder N, Koenig F, Bombien R, Fano C, Reichart B, Wintermantel E, Schmitz C, Akra B
    ASAIO J. 2013;59(3): 309-16

  3. Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation.
    Madariaga ML, Michel SG, Tasaki M, Villani V, La Muraglia GM, Sihag S, Gottschall J, Farkash EA, Shimizu A, Allan JS, Sachs DH, Yamada K, Madsen JC
    Am J Transplant. 2013;13(10): 2558-66

  4. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.
    Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M
    Anesthesiology. 2013;118(1): 40-50

  5. Facial emphysema after insertion of gastric tube.
    Bruegger D, Schwarz F, Reichart B, Chappell D
    Ann Thorac Surg. 2013;95(5): 1805

  6. Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation.
    Beiras-Fernandez A, Weis F, Rothkopf J, Kaczmarek I, Ledderose C, Dick A, Keller T, Beiras A, Kreth S
    Ann Transplant. 2013;18: 643-50

  7. Norepinephrine versus dopamine pretreatment of potential heart donors - impact on long-term outcome.
    von Ziegler F, Helbig S, Kreissl N, Meiser B, Becker A, Kaczmarek I
    Ann Transplant. 2013;18: 320-6

  8. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.
    Solomon C, Hagl C, Rahe-Meyer N
    Br J Anaesth. 2013;110(6): 947-56

  9. Transfemoral access for valve in valve implantation of an Edwards Sapien XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance.
    Greif M, Schramm R, Steinbeck G, Hagl C, Schmitz C, Kupatt C
    Can J Cardiol. 2013;29(8): 1014.e3-4

  10. Transcatheter aortic-valve endocarditis confirmed by transesophageal echocardiography.
    Orban M, Sinnecker D, Mair H, Nabauer M, Kupatt C, Schmitz C, Massberg S, Laugwitz KL, Barthel P
    Circulation. 2013;127(2): e265-6

  11. Parameters associated with short- and midterm survival in bridging to lung transplantation with extracorporeal membrane oxygenation.
    Weig T, Irlbeck M, Frey L, Zwißler B, Winter H, Preissler G, Schramm R, Neurohr C, Dolch ME
    Clin Transplant. 2013;27(5): E563-70

  12. Cryopreserved human allografts (homografts) for the management of graft infections in the ascending aortic position extending to the arch.
    Khaladj N, Pichlmaier U, Stachmann A, Peterss S, Reichelt A, Hagl C, Haverich A, Pichlmaier M
    Eur J Cardiothorac Surg. 2013;43(6): 1170-5

  13. Malposition of a venous extracorporal life support cannula in a patent foramen ovale.
    Reichelt A, Pichlmaier M, Hagl C, Khaladj N
    Eur J Cardiothorac Surg. 2013;43(2): 441

  14. Total aortic arch replacement with a novel four-branched frozen elephant trunk graft: first-in-man results.
    Shrestha M, Pichlmaier M, Martens A, Hagl C, Khaladj N, Haverich
    Eur J Cardiothorac Surg. 2013;43(2): 406-10

  15. Renal recovery after conversion to an everolimus-based immunosuppression in early and late heart transplant recipients: a 12-month analysis.
    Michel S, Bigdeli AK, Hagl C, Meiser B, Kaczmarek
    Exp Clin Transplant. 2013;11(5): 429-34

  16. Direct visualisation of microparticles in the living lung.
    Tschernig T, Veith NT, Schramm R, Laschke MW, Roller J, Rosenbruch M, Theegarten D, Bischoff M, Meier C, Menger MD
    Exp Toxicol Pathol. 2013;65(6): 883-6

  17. Type A intramural hematoma often turns out to be a type A dissection.
    Michel S, Hagl C, Juchem G, Sodian R
    Heart Surg Forum. 2013;16(6): E351-2

  18. Interventionelle Mitralklappenrekonstruktion mit dem MitraClip®-Verfahren, Patientenauswahlkriterien
    Braun D, Orban M, Tittus J, Näbauer M, Hagl C, Massberg S, Hausleiter J
    Herz. 2013;38(5): 467-73

  19. Direct in vivo observations of P-selectin glycoprotein ligand-1-mediated leukocyte-endothelial cell interactions in the pulmonary microvasculature in abdominal sepsis in mice.
    Roller J, Wang Y, Rahman M, Schramm R, Laschke MW, Menger MD, Jeppsson B, Thorlacius H
    Inflamm Res. 2013;62(3): 275-82

  20. Transcatheter valve replacement: new concepts for microsurgery inside the heart.
    Brecht R, Friedrich M, Heinisch PP, Plonien K, Akra B, Hagl C, Khoynezhad A, Lutter G, Bombien R
    Innovations (Phila). 2013;8(1): 29-36

  21. Extracorporeal life support and left ventricular ?unloading in a non-intubated patient as bridge to heart transplantation.
    Peterss S, Pfeffer C, Reichelt A, Born F, Franz W, Netz H, Kaczmarek I, Hagl C, Khaladj N
    Int J Artif Organs. 2013;36(12): 913-6

  22. An alternative immunosuppressive regimen to prolong transplant free survival in a patient with giant cell myocarditis.
    Grabmaier U, Brenner C, Methe H, Kaczmarek I, Schramm R, Klingel K, Hagl C, Franz WM
    Int J Cardiol. 2013;168(1): e27-8

  23. Sternal closure after median sternotomy: a new technique using titanium hooks and wires applied parasternally.
    Kilian E, Mair H, Reichart B, Lamm P
    Interact Cardiovasc Thorac Surg. 2013;16(6): 721-3

  24. Homografts in aortic position: does blood group incompatibility have an impact on patient outcomes?
    Vogt F, Böll BM, Boulesteix AL, Kilian E, Santarpino G, Reichart B, Schmitz C
    Interact Cardiovasc Thorac Surg. 2013;16(5): 619-24

  25. Immediate surgical coronary revascularisation in patients presenting with acute myocardial infarction.
    Khaladj N, Bobylev D, Peterss S, Guenther S, Pichlmaier M, Bagaev E, Martens A, Shrestha M, Haverich A, Hagl C
    J Cardiothorac Surg. 2013;8: 167

  26. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
    Kaczmarek I, Zaruba MM, Beiras-Fernandez A, Reimann R, Nickel T, Grinninger C, Sadoni S, Hagl C, Meiser B
    J Heart Lung Transplant. 2013;32(3): 277-84

  27. Minimally invasive aortic valve replacement with self-anchoring Perceval valve.
    Shrestha M, Timm R, Höffler K, Koigeldiyev N, Khaladj N, Hagl C, Haverich A, Sarikouch S
    J Heart Valve Dis. 2013;22(2): 230-5

  28. Elephant trunks in aortic surgery: fresh and frozen.
    Hagl C, Pichlmaier M, Khaladj N
    J Thorac Cardiovasc Surg. 2013;145(3 Suppl): S98-102

  29. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M
    J Thorac Cardiovasc Surg. 2013;145(3 Suppl): S178-85

  30. Three-dimensional printing of models for surgical planning in patients with primary cardiac tumors.
    Schmauss D, Gerber N, Sodian R
    J Thorac Cardiovasc Surg. 2013;145(5): 1407-8

  31. Everolimus in heart transplantation: an update.
    Hirt SW, Bara C, Barten MJ, Deuse T, Doesch AO, Kaczmarek I, Schulz U, Stypmann J, Haneya A, Lehmkuhl HB
    J Transplant. 2013;2013: 683964

  32. Focus on cardiac pericytes.
    Nees S, Weiss DR, Juchem G
    Pflugers Arch. 2013;465(6): 779-87

  33. Mold attacks a beating heart.
    Weig T, Irlbeck M, Neurohr C, Winter H, Schramm R, Knösel T, Horst D
    Respiration. 2013;85(1): 64-5

  34. ECMO therapy after thrombotic left main occlusion bridges prolonged cardiac arrest.
    Grabmaier U, Theiss HD, Hagl C, Franz WM
    Resuscitation. 2013;84(4): e57

  35. The role of cohabitant unusual bacterial species in infection of cardiovascular implantable electronic devices (CIED).
    Pichlmaier M, Knigina L, Kuehn C, Khaladj N, Oswald H, Klein G, Haverich A, Abraham WR
    Technol Health Care. 2013;21(1): 87-96

  36. Influence of gender on postoperative outcome after intra-aortic balloon counter-pulsation and cardiac surgery.
    Beiras-Fernandez A, Kammerer T, Heinz F, Kur F, Kiessling AH, Weis M, Hagl C, Weis F
    Thorac Cardiovasc Surg. 2013;61(1): 47-51

  37. Gender does matter: gender-specific outcome analysis of 67,855 heart transplants.
    Kaczmarek I, Meiser B, Beiras-Fernandez A, Guethoff S, Überfuhr P, Angele M, Seeland U, Hagl C, Reichart B, Eifert S
    Thorac Cardiovasc Surg. 2013;61(1): 29-36

  38. Partial inferior sternotomy and deep hypothermic circulatory arrest for rescue of a failed TAVI case: what does constitute 'inoperable'?
    Schramm R, Mair H, Becker C, Schwarz F, Bombien R, Juchem G, Sodian R, Kupatt C, Schmitz C
    Thorac Cardiovasc Surg. 2013;61(5): 431-4

  39. Transcatheter aortic valve implantation in aortic coarctation.
    Schramm R, Kupatt C, Becker C, Bombien R, Reichart B, Sodian R, Schmitz C
    Thorac Cardiovasc Surg. 2013;61(4): 336-9

  40. Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation.
    Horster S, Bäuerlein FJ, Mandel P, Raziorrouh B, Hopf C, Stemmler HJ, Guba M, Angele M, Stangl M, Rentsch M, Frey L, Kaspar M, Kaczmarek I, Eberle J, Nickel T, Gruener N, Zachoval R, Diepolder H
    Transpl Infect Dis. 2013;15(3): 306-13

  41. Platelet Factor 4-Positive Thrombi Adhering to the Ventricles of a Ventricular Assist Device in Patients with Heparin-Induced Thrombocytopenia Type II. 
    Beiras-Fernandez A, Kanzler I, Michel S, Sadoni S, Kilger E, Beiras A, Kur F
    Transplant Proc. 2013;45(5): 2013-6

  42. In vitro effects of ATG-Fresenius on immune cell adhesion.
    Kanzler I, Seitz-Merwald I, Schleger S, Kaczmarek I, Kur F, Beiras-Fernandez A
    Transplant Proc. 2013;45(5): 1846-9

  43. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I
    Transplantation. 2013;95(4): 629-34

  44. A genotype-specific, randomized controlled behavioral intervention to improve the neuroemotional outcome of cardiac surgery: study protocol for a randomized controlled trial.
    Hauer D, Kolassa IT, Laubender RP, Mansmann U, Hagl C, Roozendaal B, de Quervain DJ, Schelling G
    Trials. 2013;14: 89



Frühling_vs2 Klinikum Großhadern
Augustinum Original_vs2 Herzklinik am Augustinum
Flyer Förderverein Förderverein der Herzchirurgischen Klinik
Deckblatt_HCH_1 5 Jahre Herzchirurgie (zum Blättern rechts unten öffnen)